183 related articles for article (PubMed ID: 16753648)
1. Outcomes after detoxification for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Teesson M; Havard A; Ross J; Darke S
Drug Alcohol Rev; 2006 May; 25(3):241-7. PubMed ID: 16753648
[TBL] [Abstract][Full Text] [Related]
2. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
[TBL] [Abstract][Full Text] [Related]
4. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates.
Mills KL; Lynskey M; Teesson M; Ross J; Darke S
Drug Alcohol Depend; 2005 Mar; 77(3):243-9. PubMed ID: 15734224
[TBL] [Abstract][Full Text] [Related]
5. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Teesson M; Mills K; Ross J; Darke S; Williamson A; Havard A
Addiction; 2008 Jan; 103(1):80-8. PubMed ID: 17995994
[TBL] [Abstract][Full Text] [Related]
6. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Williamson A; Darke S; Ross J; Teesson M
Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
[TBL] [Abstract][Full Text] [Related]
7. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
[TBL] [Abstract][Full Text] [Related]
8. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS).
Havard A; Teesson M; Darke S; Ross J
J Subst Abuse Treat; 2006 Jun; 30(4):355-62. PubMed ID: 16716851
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
Darke S; Ross J; Teesson M; Ali R; Cooke R; Ritter A; Lynskey M
J Subst Abuse Treat; 2005 Apr; 28(3):255-63. PubMed ID: 15857726
[TBL] [Abstract][Full Text] [Related]
10. Changes and predictors of change in the physical health status of heroin users over 24 months.
Williamson A; Darke S; Ross J; Teesson M
Addiction; 2009 Mar; 104(3):465-70. PubMed ID: 19207357
[TBL] [Abstract][Full Text] [Related]
11. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS).
Darke S; Williamson A; Ross J; Teesson M
Drug Alcohol Rev; 2005 Sep; 24(5):425-32. PubMed ID: 16298837
[TBL] [Abstract][Full Text] [Related]
12. Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study.
Darke S; Williamson A; Ross J; Teesson M
Drug Alcohol Depend; 2006 Sep; 84(2):201-5. PubMed ID: 16580792
[TBL] [Abstract][Full Text] [Related]
13. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.
Teesson M; Havard A; Fairbairn S; Ross J; Lynskey M; Darke S
Drug Alcohol Depend; 2005 Jun; 78(3):309-15. PubMed ID: 15893162
[TBL] [Abstract][Full Text] [Related]
14. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS).
Darke S; Ross J; Mills KL; Williamson A; Havard A; Teesson M
Addict Behav; 2007 Sep; 32(9):1897-906. PubMed ID: 17289282
[TBL] [Abstract][Full Text] [Related]
15. Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Mills KL; Teesson M; Darke S; Ross J; Lynskey M
J Subst Abuse Treat; 2004 Jul; 27(1):67-73. PubMed ID: 15223096
[TBL] [Abstract][Full Text] [Related]
16. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
Darke S; Ross J; Lynskey M; Teesson M
Drug Alcohol Depend; 2004 Jan; 73(1):1-10. PubMed ID: 14687954
[TBL] [Abstract][Full Text] [Related]
17. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.
Darke S; Ross J; Williamson A; Teesson M
Addiction; 2005 Aug; 100(8):1121-30. PubMed ID: 16042642
[TBL] [Abstract][Full Text] [Related]
18. Changes in the use of medical services and prescription drugs among heroin users over two years.
Darke S; Havard A; Ross J; Williamson A; Mills KL; Teesson M
Drug Alcohol Rev; 2007 Mar; 26(2):153-9. PubMed ID: 17364850
[TBL] [Abstract][Full Text] [Related]
19. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.
Darke S; Hetherington K; Ross J; Lynskey M; Teesson M
Drug Alcohol Rev; 2004 Jun; 23(2):177-83. PubMed ID: 15370024
[TBL] [Abstract][Full Text] [Related]
20. Effects of a sustained heroin shortage in three Australian States.
Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
